InsiderClue
← All stocks

GALECTIN THERAPEUTICS INC

GALT Net buying
CIK 0001133416 #3361 in the set updated 17 Sep 2026
Bought (120 mo)
$21.12M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$24.76M
$595.80K on a plan · $11.21M straight out of an exercise
Sold at will
$12.95M
66 of 155 sales
Net
−$3.64M
+$8.17M against sales at will

By person

16 insiders · 254 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Uihlein Richard E
Director
$20.51M (7)
—
+$20.51M
55,074,229
$282.27M
+325.1%
10X Fund, L.P. entity
10% owner
—
$7.20M (42)
−$7.20M
11,385,227
$58.35M
+30.5%
CZIRR JAMES C
10% owner
—
$5.11M (16)
−$5.11M
15,907,874
$81.53M
−1.4%
CALLICUTT JACK W
Chief Financial Officer
$15.36K (2)
$4.00M (29) scheduled
−$3.98M
7,614
$39.02K
+504.3%
Shlevin Harold H.
Director
$7.54K (1)
$3.83M (24) scheduled
−$3.83M
26,123
$133.89K
−64.4%
Jamil Khurram
Chief Medical Officer
—
$1.45M (18) scheduled
−$1.45M
0
$0.00
—
TRABER PETER G
President & CEO
—
$1.16M (2) scheduled
−$1.16M
107,333
$550.10K
0.0%
Rubin Marc
Director
$12.97K (1)
$739.77K (5) scheduled
−$726.80K
13,581
$69.61K
−72.0%
LEWIS JOEL
President and CEO
$79.47K (7)
$759.19K (12) scheduled
−$679.73K
834,592
$4.28M
+3,459%
AMELIO GILBERT F
Director
—
$379.20K (4)
−$379.20K
60,614
$310.66K
+8.3%
FREEMAN KEVIN D
Director
$308.33K (31)
—
+$308.33K
192,269
$985.42K
+197.7%
ELDRED KARY
Director
$54.22K (13)
—
+$54.22K
70,107
$359.31K
+60.8%
Zordani Richard A. Jr.
Director
$50.36K (8)
—
+$50.36K
44,083
$225.93K
+202.3%
OMENN GILBERT S
Director
$79.51K (1)
$116.59K (2)
−$37.07K
66,769
$342.20K
−1.2%
ZUCCONI THEODORE DANIEL
Director
$2.27K (1)
$14.32K (1) scheduled
−$12.05K
1,083
$5.55K
+1,205%
Schwartz Elissa J.
Director
$2.00K (1)
—
+$2.00K
1,000
$5.13K
—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Individual transactions

26
Insider
Date
Role
Action
Shares
Price
Amount
Uihlein Richard E
31 Jul 2026
Director
Exercised, kept indirect
2,550,932
$4.05
$10.33M
Uihlein Richard E
31 Jul 2026
Director
Exercised, kept indirect
31,825,235
$3.00
$95.48M
CZIRR JAMES C
6 Jun 2025
10% owner
Exercised, kept
40,000
$1.11
$44.40K
CZIRR JAMES C
6 Jun 2025
10% owner
Exercised, kept
40,000
$1.98
$79.20K
CZIRR JAMES C
6 Jun 2025
10% owner
Exercised, kept
70,000
$2.11
$147.70K
CZIRR JAMES C
6 Jun 2025
10% owner
Exercised, kept
40,000
$2.11
$84.40K
CZIRR JAMES C
6 Jun 2025
10% owner
Exercised, kept
30,000
$2.86
$85.80K
CZIRR JAMES C
6 Jun 2025
10% owner
Exercised, kept
25,000
$4.72
$118.00K
CZIRR JAMES C
6 Jun 2025
10% owner
Exercised, kept
46,875
$2.39
$112.03K
CZIRR JAMES C
6 Jun 2025
10% owner
Exercised, kept
31,250
$0.89
$27.81K
Uihlein Richard E
26 Sep 2023
Director
Exercised, kept
200,000
$3.00
$600.00K
Uihlein Richard E
26 Sep 2023
Director
Exercised, kept
200,000
$3.26
$652.00K
Uihlein Richard E
26 Sep 2023
Director
Exercised, kept
200,000
$3.00
$600.00K
Uihlein Richard E
26 Sep 2023
Director
Exercised, kept
170,000
$5.00
$850.00K
Uihlein Richard E
26 Sep 2023
Director
Exercised, kept
1,466,204
$5.00
$7.33M
Uihlein Richard E
13 Feb 2020
Director
Exercised, kept
18,638
$4.72
$87.97K
Uihlein Richard E
13 Feb 2020
Director
Exercised, kept
46,875
$2.39
$112.03K
LEWIS JOEL
9 Feb 2020
Director
Exercised, kept
8,000
$2.39
$19.12K
Shlevin Harold H.
4 Jun 2019
Chief Executive Officer
Exercised, kept
8,706
$1.37
$11.93K
Uihlein Richard E
29 May 2019
Director
Exercised, kept
500,000
$5.00
$2.50M
AMELIO GILBERT F
21 Jan 2019
Director
Exercised, kept
62,250
$2.39
$148.78K
AMELIO GILBERT F
21 Jan 2019
Director
Exercised, kept
41,500
$0.89
$36.94K
10X Fund, L.P.
11 Jan 2019
10% owner
Exercised, kept
896,997
$1.12
$1.01M
10X Fund, L.P.
11 Jan 2019
10% owner
Exercised, kept
753,138
$1.49
$1.13M
10X Fund, L.P.
11 Jan 2019
10% owner
Exercised, kept
139,211
$2.69
$375.01K
10X Fund, L.P.
11 Jan 2019
10% owner
Exercised, kept
2,000,000
$3.00
$6.00M
Showing 250 of 254 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 388
Amendments (4/A) skipped 24
Filings about a different issuer 0
Unreadable filings 0
Joint filings 36
Sales on a Rule 10b5-1 plan 6
Sales straight out of an exercise 83
Sales at will 66
Transactions with no price 0
Shares from compensation/vesting 46,633,147
Sales filed before the plan box existed 58
History held since 24 Oct 2016